JP2022504949A5 - - Google Patents

Info

Publication number
JP2022504949A5
JP2022504949A5 JP2021520575A JP2021520575A JP2022504949A5 JP 2022504949 A5 JP2022504949 A5 JP 2022504949A5 JP 2021520575 A JP2021520575 A JP 2021520575A JP 2021520575 A JP2021520575 A JP 2021520575A JP 2022504949 A5 JP2022504949 A5 JP 2022504949A5
Authority
JP
Japan
Application number
JP2021520575A
Other languages
Japanese (ja)
Other versions
JP7581192B2 (ja
JPWO2020081999A5 (https=
JP2022504949A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/057034 external-priority patent/WO2020081999A1/en
Publication of JP2022504949A publication Critical patent/JP2022504949A/ja
Publication of JP2022504949A5 publication Critical patent/JP2022504949A5/ja
Publication of JPWO2020081999A5 publication Critical patent/JPWO2020081999A5/ja
Priority to JP2024096876A priority Critical patent/JP2024123097A/ja
Application granted granted Critical
Publication of JP7581192B2 publication Critical patent/JP7581192B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021520575A 2018-10-18 2019-10-18 アンドロゲン受容体モジュレーター及びその使用方法 Active JP7581192B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024096876A JP2024123097A (ja) 2018-10-18 2024-06-14 アンドロゲン受容体モジュレーター及びその使用方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862747209P 2018-10-18 2018-10-18
US62/747,209 2018-10-18
US201962803516P 2019-02-10 2019-02-10
US62/803,516 2019-02-10
US201962857516P 2019-06-05 2019-06-05
US62/857,516 2019-06-05
PCT/US2019/057034 WO2020081999A1 (en) 2018-10-18 2019-10-18 Androgen receptor modulators and methods for their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024096876A Division JP2024123097A (ja) 2018-10-18 2024-06-14 アンドロゲン受容体モジュレーター及びその使用方法

Publications (4)

Publication Number Publication Date
JP2022504949A JP2022504949A (ja) 2022-01-13
JP2022504949A5 true JP2022504949A5 (https=) 2022-10-25
JPWO2020081999A5 JPWO2020081999A5 (https=) 2022-10-25
JP7581192B2 JP7581192B2 (ja) 2024-11-12

Family

ID=70280422

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021520575A Active JP7581192B2 (ja) 2018-10-18 2019-10-18 アンドロゲン受容体モジュレーター及びその使用方法
JP2024096876A Pending JP2024123097A (ja) 2018-10-18 2024-06-14 アンドロゲン受容体モジュレーター及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024096876A Pending JP2024123097A (ja) 2018-10-18 2024-06-14 アンドロゲン受容体モジュレーター及びその使用方法

Country Status (16)

Country Link
US (3) US20200123117A1 (https=)
EP (1) EP3867216A4 (https=)
JP (2) JP7581192B2 (https=)
KR (1) KR20210093886A (https=)
CN (2) CN118684633A (https=)
AU (1) AU2019362061B2 (https=)
CA (1) CA3115101A1 (https=)
CL (1) CL2021000977A1 (https=)
CO (1) CO2021006354A2 (https=)
IL (1) IL282257A (https=)
MX (2) MX2021004427A (https=)
PE (1) PE20211543A1 (https=)
PH (1) PH12021550800A1 (https=)
SG (1) SG11202103325WA (https=)
WO (1) WO2020081999A1 (https=)
ZA (1) ZA202102202B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6884100B2 (ja) 2015-01-13 2021-06-09 ブリティッシュ コロンビア キャンサー エージェンシー ブランチ がんの画像化及び治療用のヘテロ環式化合物ならびにそれらの使用方法
US10471023B2 (en) 2015-03-12 2019-11-12 British Columbia Cancer Agency Branch Bisphenol ether derivatives and methods for using the same
US20170298033A1 (en) 2016-04-15 2017-10-19 The University Of British Columbia Bisphenol derivatives and their use as androgen receptor activity modulators
WO2019226991A1 (en) 2018-05-25 2019-11-28 Essa Pharma, Inc. Androgen receptor modulators and methods for their use
MX2021004427A (es) 2018-10-18 2021-11-12 Univ British Columbia Moduladores del receptor de andrógenos y métodos para su uso.
CN114502539A (zh) * 2019-03-28 2022-05-13 埃萨制药股份有限公司 包含雄激素受体的抑制剂的药物组合物和组合及其用途
WO2020198712A1 (en) 2019-03-28 2020-10-01 Essa Pharma, Inc. Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof
AU2020348675B2 (en) 2019-09-16 2025-11-20 Takeda Pharmaceutical Company Limited Azole-fused pyridazin-3(2H)-one derivatives
JP2021050161A (ja) 2019-09-25 2021-04-01 武田薬品工業株式会社 複素環化合物及びその用途
JP2021080177A (ja) 2019-11-14 2021-05-27 武田薬品工業株式会社 複素環化合物及びその用途
WO2021138391A1 (en) 2019-12-30 2021-07-08 Tyra Biosciences, Inc. Indazole compounds
AU2021255723A1 (en) 2020-04-17 2022-12-08 Essa Pharma, Inc. Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
CN116490165A (zh) 2020-09-02 2023-07-25 普洛佩拉治疗公司 阿比特龙前药
WO2022060969A1 (en) * 2020-09-16 2022-03-24 Essa Pharma, Inc. Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof
CN117120034A (zh) 2021-02-15 2023-11-24 普洛佩拉治疗公司 阿比特龙前药
CN115368244B (zh) * 2021-05-17 2025-08-08 北京鼎材科技有限公司 2-芳基-2-(4-胺基苯基)丙烷的合成方法
CN113603695B (zh) * 2021-08-05 2022-06-14 青岛恒宁生物科技有限公司 一种取代的嘧啶胺类化合物或其作为农药可接受的盐、组合物及其用途
WO2023031371A1 (en) 2021-09-01 2023-03-09 Janssen Pharmaceutica Nv Combination therapies for metastatic castration-resistant prostate cancer
US20240358701A1 (en) * 2021-09-01 2024-10-31 Essa Pharma Inc. Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof
JP2024533332A (ja) 2021-09-08 2024-09-12 プロペラ セラピューティクス インコーポレイテッド 経口アビラテロン製剤
WO2023056423A1 (en) * 2021-09-30 2023-04-06 Essa Pharma, Inc. Androgen receptor modulators and methods for use as bifunctional degraders
WO2023110473A1 (en) 2021-12-14 2023-06-22 Basf Se Heterocyclic compounds for the control of invertebrate pests
EP4198033A1 (en) 2021-12-14 2023-06-21 Basf Se Heterocyclic compounds for the control of invertebrate pests
KR20240167653A (ko) 2022-03-01 2024-11-27 프로펠라 쎄라퓨틱스, 인크. 아비라테론 데카노에이트 프로드러그 및 요법에서의 용도
WO2024006207A1 (en) * 2022-06-26 2024-01-04 Essa Pharma Inc. An n-terminal domain androgen receptor inhibitor and uses thereof
WO2024107928A1 (en) 2022-11-16 2024-05-23 Propella Therapeutics, Inc. Abiraterone decanoate composition and use in therapy

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571217A (en) 1951-10-16 Horace s
US2890189A (en) 1954-06-14 1959-06-09 Johnson & Son Inc S C Alkali soluble resins and compositions containing the same
US3074974A (en) 1957-12-06 1963-01-22 Monsanto Chemicals Method for the preparation of diglycidyl ether of tetrachlorobisphenol-a
US3162615A (en) 1961-01-03 1964-12-22 Dow Chemical Co Polyesters from cyclic polyhaloalkane polyols and unsaturated dicarboxylic acids
FR1389005A (fr) 1963-01-09 1965-02-12 Bayer Ag Procédé perfectionné pour durcir des polyépoxydes
SU638596A1 (ru) 1975-09-01 1978-12-25 Государственный Научно-Исследовательский И Проектный Институт Полимерных Клеев Им. Э.Л.Тер-Газаряна Хлоргидриднное производное диаллилизоциануровой кислоты в качестве пластификатора поливинилацетатной эмульсии
US4284574A (en) 1979-06-15 1981-08-18 Ciba-Geigy Corporation Diglycidyl ethers of di-secondary alcohols, their preparation, and curable compositions containing them
SU929630A1 (ru) 1980-02-06 1982-05-23 Научно-Исследовательский Институт Биологии При Иркутском Государственном Университете Им.А.А.Жданова Способ получени ди-или триоксидифенил-сульфонов
US4369298A (en) 1980-05-27 1983-01-18 Tokuyama Soda Kabushiki Kaisha Novel cured resin, process for production thereof, and lens composed of said resin from bis(alkyleneoxyphenyl)-diacrylate, bis(alkyleneoxyphenyl)diallyl ether, bis(alkyleneoxyphenyl)diallyl carbonate monomers
EP0056175B1 (en) 1981-01-13 1985-05-02 Teijin Limited Ion-permeable composite membrane and its use in selective separation
IN169231B (https=) 1984-03-15 1991-09-14 Ciba Geigy Ag
PL141793B1 (en) 1984-10-08 1987-08-31 Politechnika Warszawska Method of obtaining bisphenolic resins
US5753730A (en) 1986-12-15 1998-05-19 Mitsui Toatsu Chemicals, Inc. Plastic lenses having a high-refractive index, process for the preparation thereof and casting polymerization process for preparing sulfur-containing urethane resin lens and lens prepared thereby
JPH0832844B2 (ja) 1987-02-09 1996-03-29 パイロツトインキ株式会社 筆記板用不透明性インキ
DE3852839T2 (de) 1987-04-27 1995-06-22 Mitsubishi Gas Chemical Co Hitzehärtbare Harzzusammensetzung.
WO1988009782A1 (en) 1987-06-01 1988-12-15 The Dow Chemical Company Process for making propargyl ethers of hydroxyaromatic compounds
US5155196A (en) 1987-06-01 1992-10-13 The Dow Chemical Company Polymer resulting from the cure of a preformed chromene-containing mixture
JP2572020B2 (ja) 1987-06-19 1997-01-16 竹本油脂株式会社 熱硬化性樹脂用難燃剤
DE3821585A1 (de) 1987-09-13 1989-03-23 Hoechst Ag Positiv arbeitendes strahlungsempfindliches gemisch und daraus hergestelltes strahlungsempfindliches aufzeichnungsmaterial fuer hochenergetische strahlung
US4855184A (en) 1988-02-02 1989-08-08 Minnesota Mining And Manufacturing Company Radiation-curable protective coating composition
DE3939760A1 (de) 1989-12-01 1991-06-06 Bayer Ag Verfahren zur lackierung von kunststoffen, lackierte kunststoffe und die verwendung von hierzu geeigneten haftvermittlern
EP0515128A1 (en) 1991-05-23 1992-11-25 Konica Corporation Silver halide color photographic light-sensitive material
JPH0649473A (ja) 1992-08-04 1994-02-22 Asahi Chem Ind Co Ltd 冷媒組成物
DE4323512A1 (de) 1992-09-01 1994-04-28 Agfa Gevaert Ag Fotografisches Aufzeichnungsmaterial
DE4326393A1 (de) * 1993-08-06 1995-02-09 Merck Patent Gmbh Trifluorethoxypyri(mi)din-Derivate und flüssigkristallines Medium
JPH07117349A (ja) 1993-10-27 1995-05-09 Asahi Denka Kogyo Kk 感熱記録材料
CN1167437A (zh) 1994-11-29 1997-12-10 赫彻斯特马里恩鲁斯公司 用三芳基-乙烯衍生物治疗和预防骨质疏松的方法
DE19526146A1 (de) 1995-07-07 1997-01-09 Schering Ag Triphenylethylene, Verfahren zu deren Herstellung, diese Triphenylethylene enthaltene pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
JPH09176240A (ja) 1995-12-27 1997-07-08 Mitsubishi Chem Corp 光重合性組成物
JPH10133427A (ja) 1996-11-05 1998-05-22 Fuji Xerox Co Ltd 静電潜像現像用キャリア、静電潜像現像剤及び画像形成方法
ZA98900B (en) 1997-02-07 1998-08-03 Shell Int Research Process for the manufacture of epoxy compounds
JPH10316803A (ja) 1997-05-16 1998-12-02 Teijin Chem Ltd 難燃性樹脂組成物
IL125840A (en) 1997-08-22 2002-12-01 Teijin Chemicals Ltd Bromine compound production method
JPH11166087A (ja) 1997-12-04 1999-06-22 Teijin Chem Ltd 難燃性樹脂組成物
AU4494399A (en) 1998-06-30 2000-01-24 University Of British Columbia, The Inhibitors of androgen-independent activation of androgen receptor
US6245117B1 (en) 1998-08-07 2001-06-12 Ipposha Oil Industries Co., Ltd. Modifier of cellulose fibers and modification method of cellulose fibers
US6218430B1 (en) 1998-08-24 2001-04-17 Ligand Pharmaceuticals Incorporated Vitamin D3 mimics
JP3795679B2 (ja) 1998-09-01 2006-07-12 帝人化成株式会社 臭素化合物の製造方法
AU775928B2 (en) 1999-10-14 2004-08-19 Bristol-Myers Squibb Company Crystallographic structure of the androgen receptor ligand binding domain
US6534621B2 (en) 2000-05-18 2003-03-18 Dow Global Technologies Inc. Process for manufacturing a hydroxyester derivative intermediate and epoxy resins prepared therefrom
US6472436B1 (en) 2000-07-17 2002-10-29 The Salk Institute For Biological Studies Methods for protecting cells from amyloid toxicity and for inhibiting amyloid protein production
US6756400B2 (en) 2000-08-31 2004-06-29 Theravance, Inc. Sodium channel modulators
DE10102322A1 (de) * 2001-01-19 2002-07-25 Merck Patent Gmbh Phenylderivate
US6646102B2 (en) 2001-07-05 2003-11-11 Dow Global Technologies Inc. Process for manufacturing an alpha-dihydroxy derivative and epoxy resins prepared therefrom
US20030092724A1 (en) 2001-09-18 2003-05-15 Huaihung Kao Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
US7344700B2 (en) 2002-02-28 2008-03-18 University Of Tennessee Research Corporation Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
GB0324551D0 (en) 2003-10-21 2003-11-26 Karobio Ab Novel compounds
US7595345B2 (en) 2003-11-20 2009-09-29 Eli Lilly And Company Vitamin D receptor modulators
CA2555597C (en) 2004-02-13 2016-06-14 The University Of British Columbia Radiolabeled compounds and compositions, their precursors and methods for their production
JP2005325301A (ja) 2004-05-17 2005-11-24 Fuji Photo Film Co Ltd セルロースアシレートドープ組成物、およびセルロースアシレートフィルム
EP1781280A2 (en) 2004-08-18 2007-05-09 Warner-Lambert Company LLC Androgen modulators
JP2006208607A (ja) 2005-01-26 2006-08-10 Fuji Photo Film Co Ltd パターン形成材料、並びにパターン形成装置及び永久パターン形成方法
JP4753601B2 (ja) 2005-03-23 2011-08-24 旭化成イーマテリアルズ株式会社 感光性組成物
EP1717235A3 (en) 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
FR2885904B1 (fr) 2005-05-19 2007-07-06 Aventis Pharma Sa Nouveaux derives du fluorene, compositions les contenant et utilisation
EP1792622A1 (en) 2005-11-11 2007-06-06 GPC Biotech AG Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues
WO2007079078A1 (en) * 2005-12-29 2007-07-12 Bayer Schering Pharma Aktiengesellschaft Diamine derivatives as inhibitors of leukotriene a4 hydrolase
JP2007290980A (ja) 2006-04-21 2007-11-08 Shin Etsu Chem Co Ltd 含フッ素(メタ)アクリル酸エステル
DE102006019044A1 (de) * 2006-04-25 2007-10-31 Merck Patent Gmbh Antioxidantien
TW200819421A (en) 2006-10-31 2008-05-01 Univ Nat Chunghsing The method of synthesizing biphenol A, BPA having di-alkoxyl group by using polycarbonate or its waste
US8198311B2 (en) * 2006-11-01 2012-06-12 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
KR20090115797A (ko) 2007-02-20 2009-11-06 바스프 에스이 고굴절률 단량체, 이의 조성물 및 용도
RU2572596C2 (ru) 2008-07-02 2016-01-20 Бритиш Коламбиа Кэнсер Эйдженси Бранч Терапевтические средства на основе производных диглицилиловых простых эфиров и способы их применения
AU2009279936A1 (en) 2008-08-05 2010-02-11 Banyu Pharmaceutical Co., Ltd. Therapeutic compounds
AR079975A1 (es) 2010-01-06 2012-03-07 British Columbia Cancer Agency Agentes terapeuticos derivados de bisfenol u metodos para su uso, composiciones farmaceuticas y uso de los mismos
AR079846A1 (es) 2010-01-06 2012-02-22 British Columbia Cancer Agency Agentes terapeuticos derivados de bisfenol que contienen un grupo aquiral y su uso en el tratamiento del cancer
EP2693875A4 (en) 2011-04-08 2014-10-22 British Columbia Cancer Agency BISPHENOL COMPOUNDS AND METHOD FOR THEIR USE
WO2012145328A1 (en) 2011-04-18 2012-10-26 The University Of British Columbia Dibenzylphenyl compounds and methods for their use
WO2012145330A1 (en) 2011-04-18 2012-10-26 The University Of British Columbia Fluorene-9-bisphenol compounds and methods for their use
WO2013028572A1 (en) 2011-08-19 2013-02-28 British Columbia Cancer Agency Branch Fluorinated bisphenol ether compounds and methods for their use
WO2013028791A1 (en) 2011-08-22 2013-02-28 British Columbia Cancer Agency Branch 18f compounds for cancer imaging and methods for their use
WO2013131018A1 (en) * 2012-03-02 2013-09-06 Zalicus Pharmaceuticals Ltd. Biaryl inhibitors of the sodium channel
US9365510B2 (en) 2012-04-16 2016-06-14 British Columbia Cancer Agency Branch Aziridine bisphenol ethers and related compounds and methods for their use
CN105358522A (zh) * 2013-05-10 2016-02-24 不列颠哥伦比亚癌症局分支机构 雄激素受体调节剂的酯衍生物及其使用方法
CN103342892A (zh) 2013-06-06 2013-10-09 西安交通大学 一种双马来酰亚胺树脂的增韧改性剂及其制备方法
US20150010469A1 (en) 2013-07-03 2015-01-08 British Columbia Cancer Agency Branch Bisphenol ether compounds with novel bridging groups and methods for their use
SG11201601431VA (en) 2013-09-09 2016-03-30 British Columbia Cancer Agency Halogenated compounds for cancer imaging and treatment and methods for their use
WO2015042414A1 (en) * 2013-09-20 2015-03-26 Karyopharm Therapeutics Inc. Multicyclic compounds and methods of using same
WO2016058080A1 (en) 2014-10-14 2016-04-21 British Columbia Cancer Agency Branch Fluoro-chloro bisphenol ether compounds and methods for their use
WO2016058082A1 (en) 2014-10-14 2016-04-21 British Columbia Cancer Agency Branch 18f compounds for cancer imaging and methods for their use
JP6884100B2 (ja) * 2015-01-13 2021-06-09 ブリティッシュ コロンビア キャンサー エージェンシー ブランチ がんの画像化及び治療用のヘテロ環式化合物ならびにそれらの使用方法
US10471023B2 (en) 2015-03-12 2019-11-12 British Columbia Cancer Agency Branch Bisphenol ether derivatives and methods for using the same
CA2929345A1 (en) 2015-09-02 2017-03-02 British Columbia Cancer Agency Branch Co-targeting androgen receptor splice variants and mtor signaling pathway for the treatment of castration-resistant prostate cancer
US20170298033A1 (en) * 2016-04-15 2017-10-19 The University Of British Columbia Bisphenol derivatives and their use as androgen receptor activity modulators
WO2017210771A1 (en) 2016-06-06 2017-12-14 British Columbia Cancer Agency Branch Compounds and compositions for radiation therapy and methods of using the same
WO2018045450A1 (en) * 2016-09-09 2018-03-15 British Columbia Cancer Agency Branch Bisphenol a compounds and methods for treating drug-resistant androgen receptor mediated cancers
MX2021004427A (es) 2018-10-18 2021-11-12 Univ British Columbia Moduladores del receptor de andrógenos y métodos para su uso.

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021017339A2 (https=)
BR112021017637A2 (https=)
BR112021019377A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
BR112021017728A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112019016138A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)